Evidence base for UK drugs policy examined
17 May 2022
The Home Affairs Committee continues its inquiry into the UK’s drugs policy examining the scientific evidence base underpinning the UK’s approach. The Committee takes evidence from members of the Advisory Council on the Misuse of Drugs, which advises the Government on drugs policy, and other academic experts.
Wednesday 18 May 2022
Panel one: Independent scientists
- Professor Ornella Corazza, Professor of Addiction Science, University of Hertfordshire
- Professor Joanna Neill, Professor of Psychopharmacology, University of Manchester
- Professor David Nutt, Edmond J. Safta Professor of Neuropsychopharmacology, Imperial College London
- Professor Stuart Reece, GP and Professor of Medicine, University of Western Australia and Edith Cowan University
Panel two: Scientists from the ACMD acting in their capacity as government advisors on drugs
- Dr Owen Bowden-Jones, Chair of the ACMD and consultant in addiction psychiatry and Honorary Professor at University College London
- Dr Emily Finch, Co-Chair of the ACMD Recovery Committee and Clinical Director of the Addictions Clinical Academic Group and a Consultant Psychiatrist at South London and Maudsley NHS Trust
- Professor Roger Knaggs, Chair of the ACMD Technical Committee and Associate Professor in Clinical Pharmacy practice at the University of Nottingham
The session will examine how scientific evidence informs the policy and legislative framework used to control access to drugs in the UK. This will include the classification system and the different approaches to different types of drugs including psychoactive substances and cannabis-based products.
It will consider the potential harms and benefits of controlled drugs, and the treatments available for drug addiction and whether they are adequate.
Image: Parliamentary copyright